Cephalon

GRANIX

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Cephalon

Granix HCPCS:

J1447

HCPCS Code Descriptor:

Injection, tbo-filgrastim, 1 microgram

Category:

J Code

Granix NDCs:

63459-0912-17, 63459-0912-11, 63459-0910-17, 63459-0912-15, 63459-0920-59, 63459-0910-11, 63459-0910-15, 63459-0918-59, 63459-0912-36, 63459-0910-36

Primary Type:

Oncology Biosimilar Colony Stimulating Factor

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Granix CPT Codes:

Potential CPT administration codes for Granix can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

63459-0912-15, 63459-0920-59, 63459-0910-15, 63459-0918-59, 63459-0912-36, 63459-0910-36

About Granix:

GRANIX is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Cephalon and administered via the Subcutaneous route of administration. The J Code: J1447 is aligned to the drug GRANIX.

ACCESS PRICING AND MORE BY REGISTERING

J1447 Added Date:

January 1, 2016

J1447 Effective Date:

January 1, 2016

J1447 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Granix billing and coding information.
Granix patient assistance information can be found through Teva Cares at the URL: http://www.tevacares.org/
GRANIX prescribing information can be found at the link below:
Information regarding GRANIX’s side effects can be found at MedlinePlus